No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Non-Industrial Robots Market is Expand at a CAGR of 18.8% During Forecast Period – By Fact.MR

Editor: What To Know

  • Due to the growing demand from end-use sectors like healthcare, the military, research and development, and other industries, non-industrial robots are expected to experience rapid growth.
  • For instance, the use of robots to spy, deliver goods and services, rescue operations, robot dogs for search missions, and others.
  • MR has provided detailed information about the price points of key manufacturers of non-industrial robots positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Robotics is gradually changing how routine tasks are carried out; their adoption simplifies work, saves time, and increases overall productivity.

Every industry, including the commercial and domestic sectors, uses robots for all jobs, simple or complex. Due to the growing demand from end-use sectors like healthcare, the military, research and development, and other industries, non-industrial robots are expected to experience rapid growth.

“Demand across Defense Sector to Supplement Non-Industrial Robots Sales”

Robots with the advancing technology, witness high adoption across various end-use verticals over the period. The defense sector creates high growth opportunities for non-industrial robots as they ease out difficult military tasks.

For instance, the use of robots to spy, deliver goods and services, rescue operations, robot dogs for search missions, and others. Such factors augment the sales of non-industrial robots.

Further, the use of sensors, autonomy, navigation/control systems, and energy/propulsion systems, among others, assists military personnel to accomplish the mission efficiently. Owing to such factor military is spending highly on non-industrial robots.

Competitive Analysis

Prominent non-industrial robots Diligent Robotics, ReWalk Robotics, Barrett Advanced Robotics, Stryker, Hanson Robotics, Pal Robotics, UBTECH Robotics, Macco Robotics, Intuitive Robots, Samsung Electronics, and Skydio Robots, among others.

Market titans are experiencing high demand for non-industrial robots due to their adoption across various end-use verticals. Manufacturers are also integrating robots with advanced technology to enhance their performance and cater to the needs of the end-users. In addition, long-term trade relations with end-users enable market players to survive in unfavourable trade situations.

Fact.MR has provided detailed information about the price points of key manufacturers of non-industrial robots positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

 

These insights are based on a report on Non-Industrial Robots Market by Fact.MR. 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy